JF
BCYC

Jump Financial’s Bicycle Therapeutics BCYC Stock Holding History

Jump Financial’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
167,100
+114,556
+218% +$525K 0.01% 1334
2026
Q1 		$244K Buy
52,544
+21,544
+69% +$123K ﹤0.01% 1577
2025
Q4 		$219K Buy
31,000
+9,579
+45% +$70.6K ﹤0.01% 1697
2025
Q3 		$166K Buy
21,421
+4,681
+28% +$35.3K ﹤0.01% 1673
2025
Q2 		$116K Buy
+16,740
New +$133K ﹤0.01% 1651
2024
Q4 		– Sell
-11,600
Closed -$263K – 1648
2024
Q3 		$263K Sell
11,600
-17,372
-60% -$401K 0.01% 1361
2024
Q2 		$586K Buy
+28,972
New +$655K 0.01% 1071
2024
Q1 		– Sell
-77,332
Closed -$1.4M – 1901
2023
Q4 		$1.4M Buy
77,332
+40,265
+109% +$666K 0.04% 538
2023
Q3 		$745K Buy
37,067
+18,906
+104% +$432K 0.03% 812
2023
Q2 		$463K Sell
18,161
-19,576
-52% -$455K 0.02% 1072
2023
Q1 		$803K Buy
37,737
+30,337
+410% +$761K 0.03% 692
2022
Q4 		$219K Buy
+7,400
New +$199K 0.01% 1238
2022
Q2 		– Sell
-28,176
Closed -$1.24M – 1619
2022
Q1 		$1.24M Sell
28,176
-3,031
-10% -$142K 0.05% 450
2021
Q4 		$1.9M Buy
31,207
+14,007
+81% +$773K 0.12% 221
2021
Q3 		$715K Buy
+17,200
New +$602K 0.05% 380

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jump Financial's BCYC Position: Q2 2026 in Review

Jump Financial increased its Bicycle Therapeutics (BCYC) stake by 218% in Q2 2026, buying an estimated $525K and bringing the position to 167,100 shares worth $709K. The position accounts for 0.01% of the portfolio, ranked #1334.

Jump Financial first reported a position in BCYC in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.9M in Q4 2021. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Jump Financial held 167,100 shares of Bicycle Therapeutics worth $709K as of Q2 2026.
  • Jump Financial bought 114,556 Bicycle Therapeutics shares in Q2 2026, an estimated $525K.
  • Bicycle Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1334 holding.
  • Jump Financial first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 15 quarters since.
  • Jump Financial's Bicycle Therapeutics position peaked at $1.9M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.